MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read MoreTop Stories
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Preprints, MedRxiv, and Pharma – An Overview
Non-peer reviewed and unpublished manuscripts, aka preprints, are slowly being embraced by the pharma industry...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Artificial Intelligence Is Democratizing Research and There’s More to Come
Today AI technologies are employed to both create and consume research. Scientists across the world...
Knowledge Exchange in a New Virtual World: How the Pandemic Redefined MSL-HCP Interactions
The pandemic threw a curve ball at MSL-HCP relationships, which have traditionally relied on face-to-face...
Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence
The right AI–powered tools and techniques can make a significant difference in how research is...
The Battle for Evidence-Based Truth in a War of Misinformation
I was talking to someone I know — let’s call her Joanna — about the...